Literature DB >> 22047027

Cancer control and prevention by nutrition and epigenetic approaches.

Mukesh Verma1.   

Abstract

SIGNIFICANCE: Epigenetics involves alterations in gene expression without changing the nucleotide sequence. Because some epigenetic changes can be reversed chemically, epigenetics has tremendous implications for disease intervention and treatment. RECENT ADVANCES: After epigenetic components in cancer were characterized, genes and pathways are being characterized in other diseases such as diabetes, obesity, and neurological disorders. Observational, experimental, and clinical studies in different diseases have shown that nutrients influence epigenetic regulation. Nutrients such as folic acid that supply methyl groups have been shown to have a protective effect in colon cancer. CRITICAL ISSUES: Identifying steps during epigenetic regulation and developing intervention and treatment agents are the critical issues in the field. FUTURE DIRECTIONS: Following completion and validation of key observational studies in nutritional epigenetics, strategies can be developed for cancer control and treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22047027      PMCID: PMC3357077          DOI: 10.1089/ars.2011.4388

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  86 in total

1.  DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age.

Authors:  Elmar W Tobi; Bastiaan T Heijmans; Dennis Kremer; Hein Putter; Henriette A Delemarre-van de Waal; Martijn J J Finken; Jan M Wit; P Eline Slagboom
Journal:  Epigenetics       Date:  2011-02-01       Impact factor: 4.528

Review 2.  Nutrition and cancer: essential elements for a roadmap.

Authors:  J A Milner
Journal:  Cancer Lett       Date:  2008-07-02       Impact factor: 8.679

Review 3.  Epigenetics and hypertension.

Authors:  Richard M Millis
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

4.  Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver.

Authors:  Chun-Min Chang; Chu-Ching Yu; Hsin-Te Lu; Yi-Fang Chou; Rwei-Fen S Huang
Journal:  Br J Nutr       Date:  2007-05       Impact factor: 3.718

Review 5.  Vitamin Bs, one carbon metabolism and prostate cancer.

Authors:  K V Donkena; H Yuan; C Y F Young
Journal:  Mini Rev Med Chem       Date:  2010-12       Impact factor: 3.862

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 7.  Histone deacetylases and the immunological network: implications in cancer and inflammation.

Authors:  A Villagra; E M Sotomayor; E Seto
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

Review 8.  Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review.

Authors:  D F Carr; G Whiteley; A Alfirevic; M Pirmohamed
Journal:  Pharmacogenomics J       Date:  2009-07-07       Impact factor: 3.550

Review 9.  Dietary components impact histone modifications and cancer risk.

Authors:  Cindy D Davis; Sharon A Ross
Journal:  Nutr Rev       Date:  2007-02       Impact factor: 7.110

10.  The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate cancer.

Authors:  Maria H Traka; Caroline A Spinks; Joanne F Doleman; Antonietta Melchini; Richard Y Ball; Robert D Mills; Richard F Mithen
Journal:  Mol Cancer       Date:  2010-07-13       Impact factor: 27.401

View more
  7 in total

Review 1.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

Review 2.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

3.  Cancer-predicting gene expression changes in colonic mucosa of Western diet fed Mlh1+/- mice.

Authors:  Marjaana Pussila; Laura Sarantaus; Denis Dermadi Bebek; Satu Valo; Nima Reyhani; Saara Ollila; Essi Päivärinta; Päivi Peltomäki; Marja Mutanen; Minna Nyström
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

Review 4.  Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.

Authors:  Alessandra Bosutti; Fabrizio Zanconati; Gabriele Grassi; Barbara Dapas; Sabina Passamonti; Bruna Scaggiante
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

Review 5.  Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.

Authors:  Faraz Bishehsari; Mahboobeh Mahdavinia; Michele Vacca; Reza Malekzadeh; Renato Mariani-Costantini
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

6.  Diabetes and risk of cancer.

Authors:  Samy L Habib; Maciej Rojna
Journal:  ISRN Oncol       Date:  2013-02-07

Review 7.  The interaction between epigenetics, nutrition and the development of cancer.

Authors:  Karen S Bishop; Lynnette R Ferguson
Journal:  Nutrients       Date:  2015-01-30       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.